Clinical Trials Browser

Melanoma × Surgical Procedures, Operative × 90 days × Clear all

NCT04708418 2026-03-18

A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma

Phase 2 Active not recruiting

Melanoma